FDA Single-Use Device Reuse Policy Could Be More Stringent By Spring
This article was originally published in The Gray Sheet
FDA's policy exempting single-use device reprocessors from requiring 510(k) clearance may undergo a significant reconsideration in the Center for Devices and Radiological Health by next spring, Office of Compliance Special Assistant to the Director Caspar Uldricks told attendees of the Food & Drug Law Institute's 42nd Annual Education Conference Dec. 17 in Washington, D.C.
You may also be interested in...
Strong top-line efficacy in pyruvate kinase deficiency patients who don’t receive regular transfusions looks approvable, analysts say, but Agios will await data in regularly transfused patients.
ICON survey finds payers increasingly use ICER reports at multiple ‘touchpoints’ during the drug evaluation and decision-making process and the most common use reported in 2020 was as a reference in rebate and pricing negotiations.
Results of a forthcoming APhA survey showed about one-third cannot store Pfizer/BioNTech's BNT162b2, but can handle Moderna's mRNA-1273.